Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice

Area of Science:

• Immunology
• Neuroscience
• Autoimmune Diseases

Background:

• Intercellular adhesion molecule (ICAM)-1 (CD54) is an immunoglobulin superfamily member mediating leukocyte adhesion and extravasation via binding to lymphocyte function-associated antigen-1 (LFA-1) and macrophage-1 antigen (Mac-1).
• ICAM-1:LFA-1/Mac-1 interactions are implicated in leukocyte activation and movement, suggesting a role in autoimmune disease pathogenesis.

Purpose of the Study:

• To investigate the role of ICAM-1 in the development of experimental autoimmune encephalomyelitis (EAE), a model for autoimmune disease.
• To elucidate ICAM-1's specific functions in T-cell activation and autoimmune neuroinflammation.

Main Methods:

• Studied EAE development in mice genetically deficient in ICAM-1.
• Analyzed T-cell proliferation and cytokine production (TH1 and TH2 types) in response to myelin antigens.
• Assessed EAE severity, mortality, and central nervous system (CNS) inflammation.

Main Results:

• ICAM-1-deficient mice showed reduced T-cell proliferation and TH1-type cytokine production but increased TH2-type IL-10 production.
• EAE severity, mortality, and CNS inflammation were significantly enhanced in ICAM-1-deficient mice.
• The cellular composition of CNS inflammatory infiltrates remained similar between control and ICAM-1-deficient mice.

Conclusions:

• ICAM-1 is involved in activating autoreactive TH-1 cells but not TH2 cells.
• ICAM-1 plays a critical role in suppressing or down-regulating autoimmune inflammation within the central nervous system.